Nolan Mangini Siobhan 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Jul 1, 2022
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+100,000→ 100,000 totalExercise: $12.78Exp: 2032-06-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period measured from from July 1, 2022, with 1/48th of the shares vesting on a monthly basis, subject to the reporting person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan) as of each such vesting date.